Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oliceridine vs sufentanil for hypoxemia during hysteroscopic procedures
ChiCTR2600118685Phase 4Not yet recruiting
- Sponsor
- Yantai Affiliated Hospital of Binzhou Medical College
- Start
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of oliceridine in anoxemia (2 arms), sponsored by Yantai Affiliated Hospital of Binzhou Medical College. Primary endpoint: Incidence of hypoxia during hysteroscopic procedures. Planned start Feb 2026; status: not yet recruiting.
02
Drugs
oliceridine
03
Conditions
anoxemia
Beyond the preview
Go deeper on ChiCTR2600118685.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600118685.